DK

Debjit Kundu

Active Director Director DIN 03072294
DIN 03072294 First appointment Jul 2010 Primary industry Life Sciences
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2010
Shareholding value •••• Premium profile

About Debjit Kundu

Data last updated:

Debjit Kundu is a Director at Coulgen Biotech Private Limited (since 2010). The company operates in Life Sciences. Coulgen Biotech Private Limited reported revenue of ₹1.06 Cr (FY 2024).

DIN 03072294
Primary Designation Director
Industry Life Sciences
First Appointment 21 Jul 2010
Oldest Company Age 16 yrs
Largest company Coulgen Biotech Private Limited · ₹1.06 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Coulgen Biotech Private Limited U74900DL2010PTC206129
Director21 Jul 20102010₹1.06 Cr (FY 2024)Active

Board colleagues of Debjit Kundu

NameDINCompanyDesignation
Debjani Kundu03072269Coulgen Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Coulgen Biotech Private Limited
Premium access

Shareholding and investment profile for Debjit Kundu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Debjit Kundu

Debjit Kundu currently holds 1 directorship: Coulgen Biotech Private Limited (Director, since 21 Jul 2010, revenue ₹1.06 Cr (FY 2024)).

Debjit Kundu was first appointed on 21 Jul 2010 as Director at Coulgen Biotech Private Limited.

The current boards of Debjit Kundu's companies include Debjani Kundu (Coulgen Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available